This website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties and are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

Such statements are based upon current plans, estimates and expectations that are subject to various risks and uncertainties. The inclusion of forward-looking statements should not be regarded as a representation that such plans, estimates and expectations will be achieved. Words such as “anticipates,” “believes,” “hopes,” “estimates,” “looks,” “expects,” “plans,” “intends,” “goal,” “potential,” “may,” “suggest,” and words and terms of similar substance used in connection with any discussion of future plans, actions or events identify forward-looking statements. All statements, other than historical facts are forward-looking statements.

Among other factors that could cause actual results to differ materially from those expressed in forward-looking statements are QSAM Therapeutics, Inc. (”QSAM”) need for, and the availability of, substantial capital in the future to fund its operations and research and development; the fact that QSAM’s vaccines and therapeutics may not successfully complete pre-clinical or clinical testing, or be granted regulatory approval to be sold and marketed in the United States or elsewhere. Additionally, any potential or proposed indications, product claims, comparative claims have to be proven to the satisfaction of the FDA through clinical trials, which may or may not be successful. Although management personnel experience is significant, management, economic, or operational risks due to the pandemic or for other reasons do exist, and could affect the ability of QSAM to achieve its goals and adequate results. A more complete description of these risk factors is included in QSAM’s filings with the Securities and Exchange Commission (sec.gov). Readers are urged to consider all factors carefully in evaluating these forward-looking statements, and not to place undue reliance on any forward-looking statements.

Readers should also carefully review the risk factors described in other documents that QSAM files from time to time with the Securities and Exchange Commission. The forward-looking statements in this document speak only as of the date of these materials. Except as required by law, QSAM assumes no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.